King Pharmaceuticals KG Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $272K— | $281K— | $60K— | $2.89M— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$12.93M-809% | -$18.74M-1,093% | $31.42M— | $7.67M— | -$1.42M— | ||
| —— | —— | —— | —— | -$828.75K— | ||
| $8.3M— | $6.96M— | $6.55M— | $1.06M— | $0— | ||
| -$7.03M— | -$6.52M— | -$4.31M— | -$1.33M— | —— | ||
| -$71.02M— | -$54.28M— | -$47.25M— | -$25.09M— | —— | ||
| -$110.4M— | -$96.14M— | -$30.65M— | -$21.44M— | —— | ||
| $11.79M— | $9.53M— | $7.46M— | $1.38M— | —— | ||
| $100.91M— | $62.79M— | $15.19M— | $7.31M— | —— | ||
| $28K— | $21K— | $18K— | $1K— | —— | ||
| $1.55M— | $1.08M— | $604K— | $490K— | —— | ||
| —— | —— | —— | —— | —— | ||
| $199.94M— | $146.95M— | $104.41M— | $88.33M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$40M— | —— | ||
| —— | —— | —— | $661K— | —— | ||
| —— | —— | $34.26M— | $27.56M— | —— | ||
| —— | -$2.81M— | -$2.11M— | -$1.41M— | -$703.25K— | ||
| —— | $11.34M— | $8.5M— | $5.67M— | $2.83M— | ||
| —— | $48K— | $36K— | $24K— | $12K— | ||
| -$3.63M— | -$2.95M— | -$1.93M— | -$1.19M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $8.3M— | $6.96M— | $6.55M— | $1.06M— | $0— | ||
| —— | -$2.81M— | -$2.11M— | -$1.41M— | -$703.25K— | ||
| $23K— | $24K— | -$24K— | $0— | —— | ||
| —— | —— | $945K— | $801K— | —— | ||
| -$12.93M-809% | -$18.74M-1,093% | $31.42M— | $7.67M— | -$1.42M— | ||
| -$71.02M— | -$54.28M— | -$47.25M— | -$25.09M— | —— | ||
| —— | —— | —— | —— | -$828.75K— | ||
| -$10.28M— | -$9.91M— | -$730K— | -$93K— | —— | ||
| —— | —— | -$5.37M— | $3.59M— | —— | ||
| -$7.03M— | -$6.52M— | -$4.31M— | -$1.33M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $28K— | $21K— | $18K— | $1K— | —— | ||
| $1.55M— | $1.08M— | $604K— | $490K— | —— | ||
| $11.79M— | $9.53M— | $7.46M— | $1.38M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $100.91M— | $62.79M— | $15.19M— | $7.31M— | —— | ||
| —— | —— | $1.23M— | $668K— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does King Pharmaceuticals generate?
- King Pharmaceuticals (KG) generated -$110.4M in operating cash flow over the trailing twelve months.
- Where does King Pharmaceuticals's cash flow data come from?
- Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
